EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Saliva-Based Targeted Capture Sequencing Panel for NSCL/P-Associated Variants in a Chinese Pilot Cohort: Development and Preliminary Feasibility Assessment

Mengying Jin, Yahui Zhang, Wenyang Wang, Kaiyan Wang, Zimo Wang, Hongying Lin, Yang An

Genes · 07.11.2026 · 17 (11) · 1405

DOI: 10.3390/genes17111405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 07.11.2026. Verfasst von Mengying Jin und 6 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peking University Third Hospital, Beijing Municipal Natural Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-syndromic cleft lip and/or palate (NSCL/P) is a common congenital craniofacial malformation in Asia that severely impacts facial aesthetics and developmental health. Genetic counseling may support family counseling and risk assessment, but practical targeted approaches tailored to Chinese populations remain limited.

Methods

A saliva-based targeted capture sequencing panel was developed for NSCL/P-associated variants using genes selected from East Asian genome-wide association studies and published literature. The panel included 116 genes/loci and 77,179 biotinylated 100 bp probes. Technical feasibility was preliminarily assessed in a retrospective pilot cohort of 16 patients with NSCL/P and 10 unaffected controls. Saliva-derived DNA underwent library construction, liquid-phase hybridization capture, Illumina sequencing, and variant annotation using GATK and VEP.

Results

The selected genes span 14 functional categories, including cell metabolism, neural development, and key signaling pathways (SHH, WNT, and TGF-β). Nonsynonymous variants were reported in 13 of 16 patients with NSCL/P (81.3%; 95% CI 54.4–96.0%), whereas no qualifying nonsynonymous variants were reported in the 10 unaffected controls (0.0%; 95% CI 0.0–30.8%). Of the 22 reported nonsynonymous exonic variant entries, 20 (90.9%) were single-nucleotide variants. PTCH1 accounted for 6 of the 22 entries (27.3%).

Conclusions

This exploratory pilot study provides preliminary evidence supporting the technical feasibility of saliva-based targeted capture sequencing for detecting candidate NSCL/P-associated variants in a Chinese pilot cohort. Its relatively low testing cost after probe customization suggests potential scalability for larger cohorts. However, the small sample size limits the generalizability of these findings, and analytical performance, diagnostic yield, clinical benefit, and formal cost-effectiveness remain to be established through larger, independent prospective studies.

Förderung

  • Peking University Third Hospital
  • Beijing Municipal Natural Science Foundation

Zitieren

APA

Jin, M., Zhang, Y., Wang, W., Wang, K., Wang, Z., Lin, H., & An, Y. (2026). A Saliva-Based Targeted Capture Sequencing Panel for NSCL/P-Associated Variants in a Chinese Pilot Cohort: Development and Preliminary Feasibility Assessment. Genes, 17(11), 1405. https://doi.org/10.3390/genes17111405

Vancouver

Jin M, Zhang Y, Wang W, Wang K, Wang Z, Lin H, et al. A Saliva-Based Targeted Capture Sequencing Panel for NSCL/P-Associated Variants in a Chinese Pilot Cohort: Development and Preliminary Feasibility Assessment. Genes. 2026;17(11):1405. doi:10.3390/genes17111405

BibTeX
@article{Jin2026,
  author = {Jin, Mengying and Zhang, Yahui and Wang, Wenyang and Wang, Kaiyan and Wang, Zimo and Lin, Hongying and An, Yang},
  title = {A Saliva-Based Targeted Capture Sequencing Panel for NSCL/P-Associated Variants in a Chinese Pilot Cohort: Development and Preliminary Feasibility Assessment},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {11},
  pages = {1405},
  doi = {10.3390/genes17111405}
}
Kostenlos starten →